<--- Back to Details
First PageDocument Content
Biotechnology / Biology / Pharmacology / Biosimilar / Drugs / Biopharmaceutical / Orphan drug / Thommessen / Pharmaceutical industry in India
Date: 2015-09-23 06:21:01
Biotechnology
Biology
Pharmacology
Biosimilar
Drugs
Biopharmaceutical
Orphan drug
Thommessen
Pharmaceutical industry in India

ATTORNEY LISTINGS Advisory Judicial Review (Dispute Litigation)

Add to Reading List

Source URL: www.managingip.com

Download Document from Source Website

File Size: 276,38 KB

Share Document on Facebook

Similar Documents

INDUSTRY ISSUES What Is a Biopharmaceutical?

DocID: 1v8Wa - View Document

Curtana Pharmaceuticals Selected to Present at Inaugural University Startups Demo Day in Washington, DC AUSTIN, TX – September 7, 2016 – Curtana Pharmaceuticals, a privately-held, preclinical stage biopharmaceutical

DocID: 1v7ko - View Document

INDUSTRY ISSUES What Is a Biopharmaceutical?

DocID: 1v72B - View Document

Beyond Operational Excellence through Digital Continuity Sustainable Health for Biopharmaceutical Manufacturing by Julie Fraser and Amy Rowell

DocID: 1v5W2 - View Document

TERMINOLOGY What is a Biopharmaceutical?

DocID: 1v5mX - View Document